Wall St muted as investors track progress of US-China trade talks

U.S. stock indexes traded mixed on Tuesday as investors awaited progress in U.S.-China trade talks and key consumer price data, with the World Bank cutting its 2025 global growth forecast due to tariff concerns. The S&P 500 and Nasdaq remained about 2% and 2.6% below their all-time highs, respectively, while sector performance was varied, with energy leading gains and megacap stocks showing mixed results; Insmed surged on positive drug trial data, while J.M. Smucker's shares declined sharply after a disappointing profit forecast.

Analysis

U.S. equity markets exhibited subdued and volatile trading as investors awaited clarity on U.S.-China trade negotiations, with the Dow Jones Industrial Average rising a marginal 0.02% to 42,768.67, the S&P 500 gaining 0.10% to 6,011.84, and the Nasdaq Composite declining 0.04% to 19,582.75. While there are hints of progress in trade talks, the lack of a definitive deal contributes to choppy price action, as noted by Nuveen's Laura Cooper. This uncertainty follows relief from a preliminary deal last month, which was subsequently clouded by U.S. allegations regarding China's rare earth mineral exports. Sector performance was mixed, with energy leading gains at 1.9%, tracking higher oil prices, and communication services adding 0.8%. Despite the current volatility, the S&P 500 and Nasdaq saw their best monthly gains since November 2023 in May, positioning the S&P 500 approximately 2% below its February all-time high and the Nasdaq about 2.6% from its December record. Adding to macroeconomic concerns, the World Bank revised its 2025 global growth forecast downwards by 0.4 percentage points to 2.3%, Citing higher tariffs and heightened uncertainty as significant headwinds. Significant single-stock movements included Insmed (INSM) shares surging 27% on positive mid-stage drug trial results, while J.M. Smucker (SJM) shares declined 12.3%, set for their worst day on record, following a disappointing annual profit forecast. Tesla (TSLA) shares advanced 3.6%. Market breadth was positive, with advancers outnumbering decliners on both the NYSE (1.91-to-1) and Nasdaq (1.47-to-1). Investors are also anticipating Wednesday's U.S. consumer prices data for further guidance on the Federal Reserve's monetary policy.

Key Decisions for Investors

• Investors should maintain a cautious stance given the ongoing U.S.-China trade uncertainty and the World Bank's reduced global growth forecast for 2025, which could continue to drive market volatility.
• Closely monitor the upcoming U.S. consumer price data, as it will be a key input for assessing the Federal Reserve's potential interest rate trajectory and could significantly impact market sentiment.
• Focus on stock-specific catalysts and fundamentals, as demonstrated by the significant divergence between Insmed's positive drug trial reaction and J.M. Smucker's negative response to its profit outlook, suggesting opportunities may arise from individual company performance rather than broad market moves.
• Consider the outperformance of the energy sector, but remain aware that market sentiment is broadly mixed and the overall tone is uncertain, necessitating careful risk management.